Key result
S-ICD provides a safe and effective alternative to TV-ICDs for patients with low pacing risk.
Why the study?
Transvenous ICD leads have significant short- and long-term complications that offset some benefits of ICD therapy, leading to the development of the entirely subcutaneous ICD.
The subcutaneous ICD is a safe and effective alternative to transvenous ICDs for preventing sudden cardiac death, particularly in patients who do not require pacing and are at high risk for lead complications.
No takes yet. Share an insight, caveat, or question.
Subcutaneous ICD provides safe, effective option avoiding transvenous lead risks; extends evidence for leadless defibrillation in low-pacing-need patients.
Lewis et al. (2016) conducted a review in Sudden cardiac death. Subcutaneous implantable cardioverter-defibrillator vs. Transvenous ICD leads was evaluated. The entirely subcutaneous implantable cardioverter-defibrillator is a safe and effective alternative to transvenous ICDs, particularly for patients at low risk for pacing.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: